Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer

Overview of attention for article published in Clinical Cancer Research, October 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#8 of 17,708)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 53 news outlets
blogs: 4 blogs
twitter: 226 X users

facebook: 5 Facebook pages
wikipedia: 5 Wikipedia pages
reddit: 4 Redditors

Readers on

mendeley: 89 Mendeley

So far, Altmetric has seen 5 public wall posts from 5 users.

The Natural Health Clinic, 18 Jul 2019

Researchers are finding that the common cold virus kills cancer cells. In fact, 15 bladder cancer patients had cancer cells…

Vitamin and Herb Stores, 11 Jul 2019

Strain of common cold virus could revolutionize treatment of bladder…

Labome News, 08 Jul 2019

Strain of common cold virus could revolutionize treatment of bladder cancer. http://bit.ly/2Jil4jd

Премия "Просветитель", 07 Jul 2019

Ученые из Университета Суррея выяснили, что вирус Коксаки (CVA21), который относится к самым распространенным штаммам обычной про…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 1 additional Facebook posts.